Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

Intraarticular use of tranexamic acid reduces blood loss and transfusion rate after primary total knee arthroplasty.

Tille E, Mysliwietz J, Beyer F, Postler A, Lützner J.

BMC Musculoskelet Disord. 2019 Jul 27;20(1):341. doi: 10.1186/s12891-019-2715-9.

2.

Glutathione peroxidase 4 and vitamin E control reticulocyte maturation, stress erythropoiesis and iron homeostasis.

Altamura S, Vegi NM, Hoppe PS, Schroeder T, Aichler M, Walch A, Okreglicka K, Hültner L, Schneider M, Ladinig C, Kuklik-Roos C, Mysliwietz J, Janik D, Neff F, Rathkolb B, Hrabé de Angelis M, Buske C, da Silva AR, Muedder K, Conrad M, Ganz T, Kopf M, Muckenthaler MU, Bornkamm GW.

Haematologica. 2019 Jun 27. pii: haematol.2018.212977. doi: 10.3324/haematol.2018.212977. [Epub ahead of print]

3.

Activation of the NF-κB pathway alters the phenotype of MSCs in the tracheal aspirates of preterm infants with severe BPD.

Reicherzer T, Häffner S, Shahzad T, Gronbach J, Mysliwietz J, Hübener C, Hasbargen U, Gertheiss J, Schulze A, Bellusci S, Morty RE, Hilgendorff A, Ehrhardt H.

Am J Physiol Lung Cell Mol Physiol. 2018 Jul 1;315(1):L87-L101. doi: 10.1152/ajplung.00505.2017. Epub 2018 Apr 12.

4.

Gene expression profiling at birth characterizing the preterm infant with early onset infection.

Hilgendorff A, Windhorst A, Klein M, Tchatalbachev S, Windemuth-Kieselbach C, Kreuder J, Heckmann M, Gkatzoflia A, Ehrhardt H, Mysliwietz J, Maier M, Izar B, Billion A, Gortner L, Chakraborty T, Hossain H.

J Mol Med (Berl). 2017 Feb;95(2):169-180. doi: 10.1007/s00109-016-1466-4. Epub 2016 Aug 30.

5.

Verapamil inhibits tumor progression of chemotherapy-resistant pancreatic cancer side population cells.

Zhao L, Zhao Y, Schwarz B, Mysliwietz J, Hartig R, Camaj P, Bao Q, Jauch KW, Guba M, Ellwart JW, Nelson PJ, Bruns CJ.

Int J Oncol. 2016 Jul;49(1):99-110. doi: 10.3892/ijo.2016.3512. Epub 2016 May 10.

6.

Antisense inhibition of microRNA-21 and microRNA-221 in tumor-initiating stem-like cells modulates tumorigenesis, metastasis, and chemotherapy resistance in pancreatic cancer.

Zhao Y, Zhao L, Ischenko I, Bao Q, Schwarz B, Nieß H, Wang Y, Renner A, Mysliwietz J, Jauch KW, Nelson PJ, Ellwart JW, Bruns CJ, Camaj P.

Target Oncol. 2015 Dec;10(4):535-48. doi: 10.1007/s11523-015-0360-2. Epub 2015 Feb 3.

PMID:
25639539
7.

Side population cells of pancreatic cancer show characteristics of cancer stem cells responsible for resistance and metastasis.

Niess H, Camaj P, Renner A, Ischenko I, Zhao Y, Krebs S, Mysliwietz J, Jäckel C, Nelson PJ, Blum H, Jauch KW, Ellwart JW, Bruns CJ.

Target Oncol. 2015 Jun;10(2):215-27. doi: 10.1007/s11523-014-0323-z. Epub 2014 Jun 22.

PMID:
24950733
8.

Antitumor efficacy of a monoclonal antibody that inhibits the activity of cancer-associated carbonic anhydrase XII.

Gondi G, Mysliwietz J, Hulikova A, Jen JP, Swietach P, Kremmer E, Zeidler R.

Cancer Res. 2013 Nov 1;73(21):6494-503. doi: 10.1158/0008-5472.CAN-13-1110. Epub 2013 Sep 12.

9.

Stem cell-like side populations in esophageal cancer: a source of chemotherapy resistance and metastases.

Zhao Y, Bao Q, Schwarz B, Zhao L, Mysliwietz J, Ellwart J, Renner A, Hirner H, Niess H, Camaj P, Angele M, Gros S, Izbicki J, Jauch KW, Nelson PJ, Bruns CJ.

Stem Cells Dev. 2014 Jan 15;23(2):180-92. doi: 10.1089/scd.2013.0103. Epub 2013 Nov 13.

PMID:
24021093
10.

Potential of the trifunctional bispecific antibody surek depends on dendritic cells: rationale for a new approach of tumor immunotherapy.

Eissler N, Mysliwietz J, Deppisch N, Ruf P, Lindhofer H, Mocikat R.

Mol Med. 2013 Apr 30;19:54-61. doi: 10.2119/molmed.2012.00140.

11.

Trifunctional bispecific antibodies induce tumor-specific T cells and elicit a vaccination effect.

Eissler N, Ruf P, Mysliwietz J, Lindhofer H, Mocikat R.

Cancer Res. 2012 Aug 15;72(16):3958-66. doi: 10.1158/0008-5472.CAN-12-0146. Epub 2012 Jun 28.

12.

Mesenchymal stem cells and glioma cells form a structural as well as a functional syncytium in vitro.

Schichor C, Albrecht V, Korte B, Buchner A, Riesenberg R, Mysliwietz J, Paron I, Motaln H, Turnšek TL, Jürchott K, Selbig J, Tonn JC.

Exp Neurol. 2012 Mar;234(1):208-19. doi: 10.1016/j.expneurol.2011.12.033. Epub 2011 Dec 29.

PMID:
22230665
13.

Human renal cell carcinoma induces a dendritic cell subset that uses T-cell crosstalk for tumor-permissive milieu alterations.

Figel AM, Brech D, Prinz PU, Lettenmeyer UK, Eckl J, Turqueti-Neves A, Mysliwietz J, Anz D, Rieth N, Muenchmeier N, Buchner A, Porubsky S, Siegert SI, Segerer S, Nelson PJ, Noessner E.

Am J Pathol. 2011 Jul;179(1):436-51. doi: 10.1016/j.ajpath.2011.03.011. Epub 2011 May 18.

14.

Effects of the Hedgehog pathway inhibitor GDC-0449 on lung cancer cell lines are mediated by side populations.

Tian F, Mysliwietz J, Ellwart J, Gamarra F, Huber RM, Bergner A.

Clin Exp Med. 2012 Mar;12(1):25-30. doi: 10.1007/s10238-011-0135-8. Epub 2011 Apr 26.

PMID:
21519961
15.

Generation and characterization of the first inhibitory antibody targeting tumour-associated carbonic anhydrase XII.

Battke C, Kremmer E, Mysliwietz J, Gondi G, Dumitru C, Brandau S, Lang S, Vullo D, Supuran C, Zeidler R.

Cancer Immunol Immunother. 2011 May;60(5):649-58. doi: 10.1007/s00262-011-0980-z. Epub 2011 Feb 5.

PMID:
21298264
16.

Spontaneous malignant transformation of human mesenchymal stem cells reflects cross-contamination: putting the research field on track - letter.

Torsvik A, Røsland GV, Svendsen A, Molven A, Immervoll H, McCormack E, Lønning PE, Primon M, Sobala E, Tonn JC, Goldbrunner R, Schichor C, Mysliwietz J, Lah TT, Motaln H, Knappskog S, Bjerkvig R.

Cancer Res. 2010 Aug 1;70(15):6393-6. doi: 10.1158/0008-5472.CAN-10-1305. Epub 2010 Jul 14. No abstract available.

17.

Diverse hematological malignancies including hodgkin-like lymphomas develop in chimeric MHC class II transgenic mice.

Raffegerst SH, Hoelzlwimmer G, Kunder S, Mysliwietz J, Quintanilla-Martinez L, Schendel DJ.

PLoS One. 2009 Dec 31;4(12):e8539. doi: 10.1371/journal.pone.0008539.

18.

Long-term cultures of bone marrow-derived human mesenchymal stem cells frequently undergo spontaneous malignant transformation.

Røsland GV, Svendsen A, Torsvik A, Sobala E, McCormack E, Immervoll H, Mysliwietz J, Tonn JC, Goldbrunner R, Lønning PE, Bjerkvig R, Schichor C.

Cancer Res. 2009 Jul 1;69(13):5331-9. doi: 10.1158/0008-5472.CAN-08-4630. Epub 2009 Jun 9.

19.

Mycoplasma contamination of murine embryonic stem cells affects cell parameters, germline transmission and chimeric progeny.

Markoullis K, Bulian D, Hölzlwimmer G, Quintanilla-Martinez L, Heiliger KJ, Zitzelsberger H, Scherb H, Mysliwietz J, Uphoff CC, Drexler HG, Adler T, Busch DH, Schmidt J, Mahabir E.

Transgenic Res. 2009 Feb;18(1):71-87. doi: 10.1007/s11248-008-9218-z. Epub 2008 Sep 26.

PMID:
18819014
20.

Impairment of germline transmission after blastocyst injection with murine embryonic stem cells cultured with mouse hepatitis virus and mouse minute virus.

Mahabir E, Reindl K, Mysliwietz J, Needham J, Bulian D, Markoullis K, Scherb H, Schmidt J.

Transgenic Res. 2009 Feb;18(1):45-57. doi: 10.1007/s11248-008-9216-1. Epub 2008 Sep 18.

21.

Canine stem cell factor augments expression of matrix metalloproteinase-9 by CD34 cells.

Ostronoff LK, Kremmer E, Fermín ML, Fragío C, Mysliwietz J, Kolb HJ, Tejero C.

Cytotherapy. 2008;10(2):193-202. doi: 10.1080/14653240701827407.

PMID:
18368598
22.
23.

Gene transfer preferentially selects MHC class I positive tumour cells and enhances tumour immunogenicity.

Hacker UT, Schildhauer I, Barroso MC, Kofler DM, Gerner FM, Mysliwietz J, Buening H, Hallek M, King SB.

Cancer Immunol Immunother. 2006 May;55(5):547-57. Epub 2005 Jul 26.

PMID:
16044254
24.

Biochemical characterisation of the proteins encoded by the DiGeorge critical region 6 (DGCR6) genes.

Pfuhl T, Dürr M, Spurk A, Schwalbert B, Nord R, Mysliwietz J, Kremmer E, Grässer FA.

Hum Genet. 2005 Jun;117(1):70-80. Epub 2005 Apr 9.

PMID:
15821931
25.

DC-NK cell cross talk as a novel CD4+ T-cell-independent pathway for antitumor CTL induction.

Adam C, King S, Allgeier T, Braumüller H, Lüking C, Mysliwietz J, Kriegeskorte A, Busch DH, Röcken M, Mocikat R.

Blood. 2005 Jul 1;106(1):338-44. Epub 2005 Mar 15.

26.

The Fc-region of a new class of intact bispecific antibody mediates activation of accessory cells and NK cells and induces direct phagocytosis of tumour cells.

Zeidler R, Mysliwietz J, Csánady M, Walz A, Ziegler I, Schmitt B, Wollenberg B, Lindhofer H.

Br J Cancer. 2000 Jul;83(2):261-6.

27.
28.

Long-lasting unresponsiveness to polyclonal T cell-binding immunoglobulins.

Mysliwietz J, Thierfelder S.

Eur J Immunol. 1998 Jan;28(1):246-56.

29.

Induction and suppression of anti-antibodies to syngeneic T cell-binding antibodies in mice.

Kremmer E, Mysliwietz J, Thierfelder S.

Clin Exp Immunol. 1997 Jul;109(1):180-4.

30.

Preclinical evaluation of biotin labeling for red cell survival testing.

Hoffmann-Fezer G, Trastl C, Beisker W, Berg D, Obermaier J, Kessler W, Mysliwietz J, Schumm M, Filser J, Thierfelder S.

Ann Hematol. 1997 May;74(5):231-8.

PMID:
9200996
31.

Comparison of T-cell subpopulations in cats naturally infected with feline leukaemia virus or feline immunodeficiency virus.

Hoffmann-Fezer G, Mortelbauer W, Hartmann K, Mysliwietz J, Thefeld S, Beer B, Thum I, Kraft W.

Res Vet Sci. 1996 Nov;61(3):222-6.

PMID:
8938851
32.

Immunosuppression by Fc region-mismatched anti-T cell antibody treatment.

Thierfelder S, Mocikat R, Mysliwietz J, Lindhofer H, Kremmer E.

Eur J Immunol. 1995 Aug;25(8):2242-6.

PMID:
7664787
33.

Immunological approach to inhibit formation of anti-antibodies to allo- and xenogeneic anti-T cell immunoglobulin.

Mysliwietz J, Thierfelder S, Mocikat R, Kremmer E.

Eur J Immunol. 1994 Oct;24(10):2323-8.

PMID:
7925560
34.

Single as well as pairs of synergistic anti-CD4+CD8 antibodies prevent graft-versus-host disease in fully mismatched mice.

Reinecke K, Mysliwietz J, Thierfelder S.

Transplantation. 1994 Feb;57(3):458-61. No abstract available.

PMID:
8108884
35.

Coinjection of anti-interleukin-2 receptor antibody diminishes antiantibody formation during prolonged treatment with anti-CD3 antibody.

Mysliwietz J, Thierfelder S.

Transplantation. 1993 Nov;56(5):1266-9. No abstract available.

PMID:
8249136
36.

Biotin labeling as an alternative nonradioactive approach to determination of red cell survival.

Hoffmann-Fezer G, Mysliwietz J, Mörtlbauer W, Zeitler HJ, Eberle E, Hönle U, Thierfelder S.

Ann Hematol. 1993 Aug;67(2):81-7.

PMID:
8347734
37.

Antigen binding and effector functions of a chimeric antibody with a deletion of the CH1 domain and non-covalently associated kappa chains.

Mocikat R, Mysliwietz J, Lang P, Thierfelder S.

Biol Chem Hoppe Seyler. 1993 Jul;374(7):461-5.

PMID:
7692879
39.

An allogeneic immunosuppressive monoclonal anti-T cell antibody can elicit neutralizing anti-antibodies in mice.

Kremmer E, Mysliwietz J, Lederer R, Thierfelder S.

Transplant Proc. 1993 Feb;25(1 Pt 1):842-3. No abstract available.

PMID:
8094918
41.

Decline in CD4+ cell numbers in cats with naturally acquired feline immunodeficiency virus infection.

Hoffmann-Fezer G, Thum J, Ackley C, Herbold M, Mysliwietz J, Thefeld S, Hartmann K, Kraft W.

J Virol. 1992 Mar;66(3):1484-8.

42.

[T-helper and T-suppressor lymphocyte subpopulations in the peripheral blood of spontaneously FIV-positive cats].

Hoffmann-Fezer G, Thum I, Herbold M, Ackley C, Mysliwietz J, Hartmann K, Kraft W.

Tierarztl Prax. 1991 Dec;19(6):682-6. German.

PMID:
1665602
43.

Functional characterization of canine lymphocyte subsets.

Hötzl C, Kolb HJ, Holler E, Hahn J, Schumm M, Beisser K, Mysliwietz J, Rieber P, Mempel W, Wilmanns W, et al.

Ann Hematol. 1991 Jul;63(1):49-53.

PMID:
1831672
46.

Antigen density on target cells determines the immunosuppressive potential of rat IgG2b monoclonal antibodies.

Kummer U, Thierfelder S, Mysliwietz J.

Eur J Immunol. 1990 Jan;20(1):107-12.

PMID:
1968387
48.

Recognition of two epitopes of an antigen present on canine T cells but not on hemopoietic progenitors by four monoclonal antibodies.

Mysliwietz JJ, Hoffmann-Fezer G, Thierfelder S, Kolb HJ, Maldacker J.

Transplantation. 1988 Feb;45(2):443-8.

PMID:
2449751
50.

Development and properties of a monoclonal antibody specific for human ecto-5'-nucleotidase.

Kummer U, Mysliwietz J, Gutensohn W, Buschette S, Jahn H, Neuser D, Munker R.

Immunobiology. 1984 Mar;166(2):203-11.

PMID:
6327507

Supplemental Content

Loading ...
Support Center